This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Example ClinicalUseDefinition/example-interaction (Turtle)
Raw Turtle (+ also see Turtle/RDF Format Specification)
Interaction effect example
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
[a fhir:ClinicalUseDefinition ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "example-interaction"] ; #
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"^^xsd:anyURI ] ;
fhir:value [ fhir:v "brr" ]
] ) ; #
fhir:type [ fhir:v "interaction"] ; # example product interacts with other drugs
fhir:subject ( [
fhir:reference [ fhir:v "MedicinalProductDefinition/example" ]
] ) ; #
fhir:interaction [
fhir:interactant ( [
fhir:item [
a fhir:CodeableConcept ;
fhir:coding ( [
fhir:system [ fhir:v "http://ema.europa.eu/example/interactant"^^xsd:anyURI ] ;
fhir:code [ fhir:v "alphaconazole" ]
] )
]
] [
fhir:item [
a fhir:CodeableConcept ;
fhir:coding ( [
fhir:system [ fhir:v "http://ema.europa.eu/example/interactant"^^xsd:anyURI ] ;
fhir:code [ fhir:v "betaconazole" ]
] )
]
] ) ;
fhir:type [
fhir:coding ( [
fhir:system [ fhir:v "http://ema.europa.eu/example/interactionsType"^^xsd:anyURI ] ;
fhir:code [ fhir:v "Inhibitor" ]
] )
] ;
fhir:effect [
fhir:concept [
fhir:text [ fhir:v "Increased plasma concentration" ]
]
] ;
fhir:management ( [
fhir:text [ fhir:v "Careful monitoring of dose" ]
] )
]] . #
# -------------------------------------------------------------------------------------
Usage note: every effort has been made to ensure that the
examples are correct and useful, but they are not a normative part
of the specification.